Trial Profile
A Phase II Study Of Sunitinib In Combination With Irinotecan, l-Leucovorin, And 5-Fluorouracil In Patients With Unresectable Or Metastatic Colorectal Cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Sunitinib (Primary) ; Fluorouracil; Irinotecan; Levofolinic acid
- Indications Colorectal cancer
- Focus Therapeutic Use
- 16 Oct 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Jun 2010 Planned end date changed from 1 May 2010 to 1 Dec 2010 as reported by ClinicalTrials.gov.
- 05 Aug 2009 Actual patient number (72) added as reported by ClinicalTrials.gov.